Mar 31, 2021 by Morgan McSweeneyVaccine Makers vs. COVID Variants: What Are Their Strategies?Each vaccine maker's approach to tackling new variants differs in slight, but important, ways.
Mar 31, 2021 by Morgan McSweeneyHere's What You Need to Know About COVID Variants' Impact on Vaccine EfficacyDo new variants from South Africa, Brazil, and the U.K. threaten the efficacy of already authorized vaccines?
Mar 31, 2021 by Morgan McSweeneyKids and COVID: When Will They Be Vaccinated?Almost 30% of U.S. adults have received at least one dose of a coronavirus vaccine, but clinical trials of the vaccines' safety and efficacy in children are still in progress.
Mar 30, 2021 by Morgan McSweeneyCould Merck's New Antiviral Be the Next Big COVID Treatment?Merck and Ridgeback Biotherapeutics' oral pill is still in clinical testing, but preliminary results are promising.
Mar 30, 2021 by Morgan McSweeneyNew Report Shows Promising Coronavirus Vaccine DataPublic health experts and average citizens alike have been hoping that vaccines can tackle this one big issue.
Feb 8, 2021 by Morgan McSweeneyWhy Johnson & Johnson's Vaccine Data Is Actually Great NewsA few numbers from phase 3 trials stuck out for the wrong reasons. But looking closer, there's plenty to celebrate.
Feb 6, 2021 by Morgan McSweeneyHow Do mRNA Vaccines Work?Pfizer and Moderna both received FDA authorization for mRNA vaccines, and phase 3 data efficacy was sky high.
Jan 21, 2021 by Morgan McSweeneyShould You Get A Vaccine If You've Already Recovered From COVID?A doctor explains why it's smart to still get the COVID vaccine after getting infected.
